European Archives - Page 39 of 983 - European Medical Journal

Does Retreating Multiple Myeloma with Previously Refractory Drugs Work?

Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.

GLP-1 Agonists May Help Reduce Alcohol-Related Hospitalisations

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

Patrick Oliver, Alfasigma

Alfasigma’s Patrick Oliver on the company’s new chapter in the UK

Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.

Low-Dose IL-2 Shows Promise for Allergic Rhinitis Relief

In the trial, patients received either IL-2 (1 MUI/day) or a placebo for 5 days, followed by weekly doses for 4 weeks.

Neutrophil Extracellular Traps Imbalance Linked to Portal Vein Thrombosis

This study assessed neutrophil extracellular traps and DNase activity in patients with chronic hepatitis B-related decompensated cirrhosis to determine their relationship with PVT.

Racial Disparities in Pregnancy-Related Cardiovascular Mortality

New analysis finds most pregnancy-related cardiovascular deaths preventable, highlighting racial disparities and offering prevention recommendations to improve maternal health.

Revisto raises $4m to streamline pharma compliance with AI

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry’s marketing compliance processes using AI.

Two Glucocorticoid Tapering Strategies Show Similar Success in Rheumatoid Arthritis

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation in rheumatoid arthritis patients.

PlGF Testing Could Identify Risk of Adverse Birth Outcomes

Testing for low placental growth factor during routine gestational diabetes screening could identify pregnant individuals at high risk of early preterm birth.

New Study Sheds Light on Potential Treatment Target for Neuroblastoma

A new study reveals how the m6A epitranscriptomic modification and MYCN oncogene cooperate to maintain an undifferentiated state in neuroblastoma…